Medical Design Technology -
7 Mar 2019 18:00
News etectRx, a privately held digital health company, has announced that its ID-Cap System, an ingestion event monitoring technology, has been selected for a new study to observe adherence for the HIV prevention drug TRUVADA for PrEP... Contributed Author: etectRx Topics: Regenerative Medicine
Share this Article